Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC (RARE)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 10:00:04 pm
46.01 USD   -2.75%
2014Amid Alibaba fever, reasons for caution in IPO market
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ULTRAGENYX PHARMACEUTICAL
02/20/19 FY 2018 Earnings Release (Projected)
05/06/19 Q1 2019 Earnings Release (Projected)
08/05/19 Interim 2019 Earnings Release (Projected)
11/11/19 Q3 2019 Earnings Release (Projected)
Past events on ULTRAGENYX PHARMACEUTICAL
11/28/18 | 05:00pm Evercore ISI HealthconX Conference
11/27/18 | 05:30pm Piper Jaffray Health Care Conference
11/14/18 | 07:30pm Credit Suisse Healthcare Conference
11/05/18 Q3 2018 Earnings Release
Upcoming sector events for ULTRAGENYX PHARMACEUTICAL
01/03/19 | 05:00pm INCYTE CORPORATION : Goldman Sachs Health Care CEOs Unscripted Conference
01/07/19 QIAGEN NV : J.P. Morgan Healthcare Conference
01/07/19 | 06:05pm BLUEBIRD BIO INC : Alliance for Regenerative Medicine Cell & Gene Therapies Conference
01/07/19 | 10:30pm INCYTE CORPORATION : J.P. Morgan Healthcare Conference
More events
Past sector events for ULTRAGENYX PHARMACEUTICAL
12/07/18 | 02:00pm IONIS PHARMACEUTICALS INC : Investor Day
12/09/18 CHARLES RIVER LABORATORIES INTL. INC : Antibody Engineering & Therapeutics Conference
12/12/18 | 02:30pm NEUROCRINE BIOSCIENCES, INC. : T-Force GOLD Phase IIb Study Results Call
12/12/18 | 02:40pm IONIS PHARMACEUTICALS INC : BMO Prescriptions for Success Healthcare Conference
Annual publications
Previous yearNext Year
Annual results2015201620172018 (e)2019 (e)
Sales
Million $
Released
Forecast
Spread


0,13
1,07
-88%
2,61
0,43
501%

49,7

102
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-146
-133
-9,8%
-245
-239
-2,4%
-323
-319
-1,4%

-362

-331
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-148
-136
-9,0%
-248
-245
-1,3%
-329
-318
-3,3%

-376

-357
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-146
-134
-8,3%
-246
-244
-0,80%
-318
-308
-3,5%

-202

-355
Net income
Million $
Released
Forecast
Spread
-146
-135
-8,2%
-246
-244
-0,82%
-302
-299
-1,0%

-202

-356
EPS
 $
Released
Forecast
Spread
-3,96
-3,62
-9,5%
-6,21
-6,19
-0,36%
-7,12
-7,03
-1,3%

-4,00

-6,60
Announcement Date02/25/201602/16/201702/20/2018

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ1
2018
Q2
2018
Q3
2018
Q4
2018 (e)
Q1
2019 (e)
Sales
Million $
Released
Forecast
Spread
10,7
52,9
-80%
12,8
5,42
136%
11,8
11,4
3,6%

14,0

15,1
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-90,3
-24,5
-268%
-88,8
-108
18%
-85,3
-95,4
11%

-92,5


Operating profit (EBIT)
Million $
Released
Forecast
Spread
-96,5
-33,8
-185%
-94,9
-103
8,0%
-89,6
-100
11%

-94,1

-96,5
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
30,3
-15,0
302%
-52,6
-102
48%
-87,1
-99,6
13%

-92,3

-95,0
Net income
Million $
Released
Forecast
Spread
30,3
-17,2
275%
-52,7
-102
48%
-87,3
-98,8
12%

-92,3

-95,0
EPS
 $
Released
Forecast
Spread
0,62
-0,42
247%
-1,06
-2,08
49%
-1,74
-1,96
11%

-1,81

-1,83
Announcement Date05/07/201808/02/201811/05/2018

© 2018 Thomson Reuters
© 2018 Factset
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise